0.0040
-0.0001
(-2.44%)
At close: April 17 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-758.9950
-1,030.5000
-2,044.3260
-2,486.7650
-3,215.6990
Investing Cash Flow
-2.8390
--
-8.7100
-50.4950
9.9800
Financing Cash Flow
670.3800
1,139.6750
1,647.3550
2,533.0420
3,151.2700
End Cash Position
6.0440
156.4570
47.2820
452.9630
457.1810
Interest Paid Supplemental Data
--
--
177.5000
--
--
Capital Expenditure
--
--
-8.7100
-50.4950
-97.3240
Issuance of Capital Stock
370.3800
491.4560
1,742.2610
1,635.5380
3,309.1300
Issuance of Debt
300
675
1,325
1,010
--
Repayment of Debt
--
--
-1,333.2000
-120
--
Free Cash Flow
-761.8340
-1,030.5000
-2,053.0360
-2,537.2600
-3,313.0230
12/31/2020 - 9/2/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CNBX CNBX Pharmaceuticals Inc.
0.0100
+5.26%
EVLO Evelo Biosciences, Inc.
0.0005
0.00%
ARTH Arch Therapeutics, Inc.
0.2000
0.00%
ARDS Aridis Pharmaceuticals, Inc.
0.0001
0.00%
AMPE Ampio Pharmaceuticals, Inc.
0.0021
-90.34%
LIXT Lixte Biotechnology Holdings, Inc.
1.1314
-7.26%
NAVB Navidea Biopharmaceuticals, Inc.
0.0006
0.00%
ADXS Ayala Pharmaceuticals, Inc.
0.0317
0.00%
PHRM.CN PharmaTher Holdings Ltd.
0.2150
+4.88%
TTNP Titan Pharmaceuticals, Inc.
3.7300
+3.04%